The major long-term objective of these studies is to understand the regulation of plasma cholesterol levels and to determine how these levels can be effectively modified by drug therapy or by environmental manipulations. Such information would bear on the important health problems of atherosclerosis and cholesterol gallstone formation. In an initial group of investigations, methods will be developed for measuring absolute rates of both receptor-dependent and receptor-independent LDL uptake in all major organs of different animal species. Such studies will provide information on the quantitative importance of different organs for the uptake and degradation of circulating LDL and on the importance of the receptor-dependent and -independent processes. In a second group of investigations the circulating levels of LDL will be artificially altered in order to develop detailed kinetic curves for the transport of LDL into major organs by both the receptor-dependent and receptor-independent processes. These kinetic curves will provide data on the maximal transport rates and apparent Km values for the LDL uptake process and will make it possible to analyze how certain drugs and environmental manipulations alter LDL metabolism in specific organs. In a third group of investigations, detailed studies will be carried out on the mechanisms of regulation of LDL transport. In such investigations the rates of cholesterol synthesis in organs like the intestine, liver and extrahepatic tissues will be systematically altered under circumstances where both receptor-dependent and receptor-independent LDL transport will be assayed in order to explore the relationship between these two variables. In a fourth group of investigations the process responsible for the specific binding of high-density lipoproteins to endocrine cells will be further examined. In addition, the quantitative importance of cholesterol substrate derived from de novo synthesis, HDL or LDL for steroid hormone production will be assayed in the endocrine glands from different species. Finally, with the data available on the kinetics of LDL transport, it will be possible to elucidate the mechanisms of action of different drugs and dietary manipulations known to alter circulating plasma LDL levels. Taken together, the results of these studies will provide a much better understanding of the physiology of cholesterol balance and LDL metabolism in the intact animal and in man.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL009610-22
Application #
3334298
Study Section
Metabolism Study Section (MET)
Project Start
1975-06-01
Project End
1990-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
22
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Lopez, Adam M; Chuang, Jen-Chieh; Turley, Stephen D (2018) Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse. Steroids 130:7-14
Lopez, Adam M; Chuang, Jen-Chieh; Posey, Kenneth S et al. (2017) Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis. Brain Res 1654:77-84
Chuang, Jen-Chieh; Lopez, Adam M; Turley, Stephen D (2017) Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe. Biochem Pharmacol 135:116-125
Lopez, Adam M; Chuang, Jen-Chieh; Posey, Kenneth S et al. (2017) 'Corrigenda to ""Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis"" [Brain Res. 1654 (2017) 77-84]'. Brain Res 1657:383
Lopez, Adam M; Chuang, Jen-Chieh; Posey, Kenneth S et al. (2015) PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice. J Pharmacol Exp Ther 355:159-67
Jones, Ryan D; Lopez, Adam M; Tong, Ernest Y et al. (2015) Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice. Steroids 93:87-95
Ramirez, Charina M; Lopez, Adam M; Turley, Stephen D (2015) Lysosomal Acid Lipase Activity: A Tool for the Detection and Management of Fatty Liver Disease? EBioMedicine 2:638-9
Lopez, Adam M; Terpack, Sandi J; Posey, Kenneth S et al. (2014) Systemic administration of 2-hydroxypropyl-?-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Clin Exp Pharmacol Physiol 41:780-7
Chuang, Jen-Chieh; Lopez, Adam M; Posey, Kenneth S et al. (2014) Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease. Biochem Biophys Res Commun 443:1073-7
Aqul, Amal; Lopez, Adam M; Posey, Kenneth S et al. (2014) Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice. Am J Physiol Gastrointest Liver Physiol 307:G836-47

Showing the most recent 10 out of 33 publications